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Available online 30 November 2016Ataxia-Teleangiectasia (A-T) is a neurodegenerative disorder due tomutations inATMgene. ATM in the nucleus en-
sures DNA repair, while its role in the cytosol is still poorly clariﬁed. Abnormal autophagy has been documented in
other neurodegenerative disorders, thus we evaluated whether alteration in this process may be involved in the
pathogenesis of A-T by analyzing the autophagic vesicles and the genes implicated in the different stages of autoph-
agy. Through transmission electronmicroscopy (TEM) and immunoﬂuorescence analysis we observed an accumu-
lation of APs associatedwith a LC3 puncta pattern, and a reduced number of ALs.We also documented an increased
expression of genes involved in AP and lysosome biogenesis and function, and a decrease of Vps18 expression,
involved in their vesicular trafﬁcking and fusion. mTORC1-controlled proteins were hyperphosphorylated in A-T,
in keeping with an increased mTOR inhibitory inﬂuence of autophagy. Betamethasone is able to promote the
degradation of SQSTM1, a biomarker of autophagy. Collectively, our results indicate that in cells from A-T patients,
the APs maturation is active, while the fusion between APs and lysosomes is inappropriate, thus implying abnor-
malities in the cell-clearance process. We also documented a positive effect of Betamethasone on molecules impli-
cated in autophagosome degradation.
© 2016 Elsevier Inc. All rights reserved.Keywords:
Ataxia-Teleangiectasia
Autophagosomes
Autophagy
Autophagosome-lysosome fusion
Cell-clearance1. Introduction
Ataxia-Teleangiectasia (A-T) (MIM #208900) is a rare recessive
disorder characterized by cerebellar neurodegeneration with the loss
of Purkinje cells, oculocutaneous teleangiectasia, susceptibility to
cancer, growth retardation, diabetes mellitus and immunodeﬁciency
[1–3]. Recently, in a few clinical trials it has been documented that a
short-term treatment with glucocorticoids (GCs) is able to partially
rescue the A-T neurological phenotype and lymphocyte proliferation
even though the mechanism of action has not yet been deﬁned [4–7].
The improvement of cerebellar symptoms during steroid treatment
was inversely correlated with the severity of cerebellar atrophy [6]. It
has recently been documented that Dexamethasone in vitro leads to
the skipping ofmutations upstreamof nucleotide residue 8450 of Ataxia
Telangiectasia Mutated (ATM) coding sequence, resulting in a new ATM
variant with the complete kinase domain, whichwas shown to be likely
active [8].al Medical Sciences, Federico IIA-T is caused by mutations in the ATM gene encoding a serine/thre-
onine protein kinase involved in cell cycle control and repair of DNA
double-strand breaks [9,10]. Evidence exists that ATM exerts additional
functions in the cytoplasm independent of its role in the DNA damage
response [11], such as participation in the autophagy pathway [12]. To
date, many studies have been performed to identify the pathogenic
mechanism responsible for the disease, mainly focusing on the nuclear
activity of ATM protein. Thus, the pleiotropic aspects of the phenotype
have only partially been clariﬁed.
To date, A-T remains an incurable disease that leads relentlessly to
death around the third decade of life [13].
Autophagy alterations have been implicated in several chronic ner-
vous systemdisorders, such as proteinopathies (Alzheimer's, Parkinson's,
Huntington's diseases) and acute brain injuries [14], whose hallmarks are
organelle damage, synaptic dysfunction and neuronal degeneration.
Autophagy is a constitutive lysosomal catabolic process during which,
cytoplasmic components, damaged proteins and entire organelles are
degraded and recycled to generate building blocks for anabolic processes.
Autophagy, known originally as an adaptive response to nutrient
deprivation in mitotic cells, including lymphocytes, is now recognized
as an arbiter of neuronal survival and homeostasis in that neurons are
post-mitotic cells, which require effective protein degradation to prevent
accumulation of toxic aggregates. Reactive oxygen species (ROS)
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from A-T patients, is a potent trigger of autophagy, which acts to clean
up damaged organelles [15]. It has been demonstrated that in the pres-
ence of elevated ROS levels, the activation of the serin/threonine kinase
ATM in the cytoplasm leads to activation of LKB1 tumor suppressor
gene, which, in turn, phosphorylates and activates AMP protein kinase
(AMPK) [16]. AMPK regulates several metabolic processes and activates
Tuberous sclerosis complex 2 (TSC2), which participates in energy sens-
ing and growth factor signaling [17]. TSC2, by inhibiting the GTPase Ras
homolog enriched in brain (Rheb), is able to repress the mechanistic tar-
get of rapamycin (mTOR) kinase, a key regulator of the protein synthesis
and cell growth, thus leading to the activation of autophagy [18]. The
repression ofmTOR complex 1 (mTORC1) signaling results in the absence
of phosphorylation of p70 ribosome S6 kinase (p70S6K) and eukaryotic
initiation factor 4E-binding protein 1 (4EBP1), direct targets of the
mTOR kinase, involved in protein synthesis and survival.
Thus, a direct effect of ATM-mediated inhibition of mTORC1 is the
activation of autophagy, a dynamic process, which includes the
initiation, formation, maturation and degradation of autophagosomes
(APs). The lipidation of the microtubule-associated protein 1 light
chain 3 (LC3) molecule, through the conjugation of phosphatidyletha-
nolamine (PE) converting the cytosolic LC3 (LC3-I) to the autophagic
vesicle-associated form (LC3-II), is essential for autophagy induction,
and thus for APs visualization by transmission electron microscopy
(TEM). The lipidated LC3-II form may also be visualized under
ﬂuorescence microscope in that it shows a punctate staining pattern
and by western blot in that it has faster electrophoretic mobility
compared with diffused LC3-I form [19]. An increase of LC3-II form
may result from either an enhancement of AP biogenesis or inhibition
of AP degradation, or may be due by other mechanisms [19]. p62/
sequestosome (SQSTM1), is a further biomarkerwidely used to evaluate
the appropriateness of autophagic activity. It can bind LC3 protein to
promote the recruitment of unwanted material into autophagosomes
and the subsequent degradation through autolysosomes. When a
normal autophagic ﬂux occurs, p62, as substrate of autophagy itself, is
degraded [20]. Thus, increased LC3-II and decreased SQSTM1 levels
are indicative of an appropriate autophagic activity whereas increased
SQSTM1 levels reveal defective autophagy [20].
Recently, genes involved in autophagosomal/lysosomal biogenesis
and lysosomal functionality, belonging to the Coordinated Lysosomal
Expression and Regulation (CLEAR) network, have been described as
crucial for a proper cell clearance through an autophagic process [21]
during catabolic conditions. In particular, the expression of the UV
Radiation Resistance Associated (UVRAG) gene plays a pivotal role in
the ﬁrst phase of the process, which consists in AP biogenesis and
formation [22,23]. To ensure a proper degradation of unwantedmaterial
and thus cell clearance, the APsmust fuse to the lysosomes that contain
several active hydrolases, such asβ-glucosidase (GBA),β-glucuronidase
(GUS) and cathepsins (CST) [21]. The fusion process depends on the
intracellular positioning of lysosomes in that, only the lysosomes that
are transported along microtubules in the perinuclear area, thanks to
kinesins (such as KIF2A and KIF1B-β and the monomeric GTPase
ARL8B), are able to fuse with APs [24]. Moreover, Vacuolar Protein
Sorting 11 and 18 (Vps11 and Vps18) protein products are also involved
in vesicular trafﬁcking to allow the encounter between APs and lyso-
somes, resulting in their fusion [25]. Eventually, the formation of
autolysosomes (ALs), whose content is degraded by lysosomal
enzymes and recycled, leads to preserved cellular homeostasis.
In the present work, we evaluated whether abnormal autophagy
may be involved in the pathogenesis of A-T by analyzing the autophagic
vesicles and the genes implicated in the different stages of autophagy
process.
Through in vitro experiments using freshly isolated lymphocytes
from A-T patients, we found that in A-T lymphocytes, under resting
conditions, there is an accumulation of APs, associated with a high ex-
pression of genes involved in the process of biogenesis and function ofAPs and lysosomes. The addition in vitro of Betamethasone helps de-
crease SQSTM1 levels, which is associated to autophagy progression.
Moreover, a reduced expression of Vps18 and Vps11molecules, involved
in the vesicular trafﬁcking and fusion between APs and lysosomes, was
also found. Taken together, our results indicate that the stage of fusion
between APs and lysosomes represents a limiting step, which leads to
AP accumulation and inappropriate cell clearance and trafﬁcking in A-T.
2. Materials and methods
2.1. Cell culture
Peripheral bloodmononuclear cells (PBMCs)were obtained from A-
T patients and healthy donors by Ficoll-Hypaque (Biochrom, Berlin,
Germany) density gradient centrifugation. Lymphoblastoid B-cell lines
(BCLs) were generated by Epstein Barr Virus (EBV) immortalization of
patients' and healthy donors' PBMCs using standard procedures, and
were grown in RPMI-1640 (Lonza, Verviers, Belgium) supplemented
with 10% fetal bovine serum (FBS; Gibco, Carlsbad, California), 2 mmol
L-glutamine (Gibco, Carlsbad, California), 50 g/ml gentamycine (Gibco,
Carlsbad, California), 10% penicillin-streptomycin (Lonza, Verviers,
Belgium), and cultured at 37 °C, 5% CO2. Serum starvation was induced
incubating the cells in mediumwithout FBS for 2 h. All the experiments
were approved by the Ethical Committee “Comitato Etico per le Attività
Biomediche Carlo Romano” of the Federico II University of Naples.
2.2. Transmission electron microscopy
PBMCs obtained from A-T patients and healthy donors were washed
in PBS and centrifuged to obtain a visible pellet. Cells were than ﬁxed
with a 1% glutaraldehyde and 0.2 M Hepes. After dehydration, from
each sample thin sectionswere cutwith a Leica EMUC7 ultramicrotome
and further investigated using a FEI Tecnai-12 (FEI, Eindhoven, The
Netherlands) electron microscope equipped with a Veletta CCD camera
for digital image acquisition at different magniﬁcations.
Autophagosomeswere identiﬁed on the basis of their ultrastructural
morphology. These vesicles have a double membrane usually visible as
two membrane bilayers, which contain cytosol and/or morphologically
intact organelles. Autolysosomes were identiﬁed on the basis of their
characteristic single limiting membrane, containing unwanted cyto-
plasmicmaterial and/or organelles at various stages of degradation [26].
2.3. Western blotting
Total lysates were obtained from lymphoblastoid B-cell lines of A-T
patients and healthy donors. The cells were pre-treated or not with
80 nM of Betamethasone (BMZ) for 2 h, 0.2 mM H2O2 for 30 min, or
100 nM Baﬁlomycin A1 (BAFA1) (Sigma-Aldrich, St. Louis, MO) for
1 h, washed with ice-cold PBS (Lonza, Walkersville, MD) and lysed in
100 μl of lysis solution containing 20 mM Tris (pH 8), 137 mM NaCl,
1% Nonidet P-40, 10 mM EDTA, 1 mM phenylmethylsulfonylﬂuoride
(PMSF), 1 mM sodium orthovanadatum (Na3VO4), 5 μg/ml leupeptin
and 5 μg/ml aprotinin on ice for 45 min. Fractioned cell lysates were
obtained from lymphoblastoid B-cell lines generated by EBV immortal-
ization of PBMCs from A-T patients and healthy donors. The cells were
treated with 0.2 mM H2O2 for 15, 30 or 60 min, washed with ice-cold
PBS and resuspended in Buffer A (10 mM Hepes/KOH pH 7.9, 1.5 mM
MgCl2, 10 m MKCl, 0.5 mM Dithiothreitol (DTT) pH 7.9, 0.5 mM PMSF,
0.5 mM Na3VO4, 5 μg/ml leupeptin and 5 μg/ml aprotinin) on ice for
10 min. Cells were centrifuged to collect the supernatant containing
the cytosolic fraction. The pellet was resuspended in Buffer C (20 mM
Hepes/KOH pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 0.5 mM Na3VO4, 5 μg/ml
leupeptin and 5 μg/ml aprotinin) on ice for 20 min. Cells were centri-
fuged to collect the supernatant containing the nuclear fraction. The
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determined by Bio-Rad Protein Assay, based on Bradford's method.
Proteins for LC3, SQSTM1, p-S6K, p-S6 and p-4EBP1 were separated on
4–12% Novex NuPAGE SDS-PAGE gels (Invitrogen, Carlsbad, CA), while
proteins for p-mTOR and mTOR were separated on 5% SDS-PAGE.
Proteins were electrophoretically transferred onto nitrocellulose
membranes (Sigma-Aldrich, St. Louis, MO). The membranes were then
washed three times in wash buffer, blocked and incubated with the
speciﬁc primary antibodies for LC3 (Biorbyt, Cambridge, UK), SQSTM1
(Fitzgerald Industries International, MA, USA), p-S6K (Thr389) (Cell
Signaling Technology), p-S6 (Ser 235/236) (Cell Signaling Technology),
p-4EBP1 (Thr37/46) (Cell Signaling Technology, MA, USA), p-mTOR
(Ser2448) (MerkMillipore, Germany), m-TOR (Santa Cruz Biotechnolo-
gy, TX, USA) or Tubulin (Biorbyt, Cambridge, UK). Immune complexes
were detected using the appropriate anti-rabbit or anti-mouse
peroxidase-linked antibodies. ECL reagent (Bio-Rad, Woodinville, WA,
USA) was used as detection system for visualization. Densitometric
analysis was performed using ImageJ software.
2.4. Real-time quantitative reverse transcriptase PCR analysis
Total RNA was extracted from ATM-deﬁcient and control PBMCs
using TRIzol reagent (Invitrogen, Carlsbad, CA), and Phase-lock gel
columns (Eppendorf, Germany) according to the manufacturer's
instructions. RNA was reverse transcribed by Transcriptor First Strand
cDNA Synthesis Kit (Roche, Germany). The qPCR reactions were
performed in duplicate. The ampliﬁcation of the cDNAs was performed
using the SYBR Green and analyzed with the Light Cycler 480 (Roche
Applied Systems, Germany). Cycling conditions comprised an initial
denaturation at 94 °C for 5 min, a phase of annealing/extension speciﬁc
for each gene. A dissociation procedure was performed to generate a
melting curve for conﬁrmation of ampliﬁcation speciﬁcity. Primers
used are listed in Table 1. Results are mean ± standard error (SE) of 2
repeated experiments and each gene expression was normalized to β-
actin as housekeeping gene. The relative transcript abundance was
represented as −DCt = (Ct gene − Ct reference) and the relative
changes in gene expressionwas analyzed using the 2−DDCtmethod [27].
2.5. Fluorescence microscopy
PBMCs obtained from A-T patients and healthy donors were washed
with PBS (Lonza, Walkersville, MD) and spotted on sterile coverslips
through Shandon CytoSpin III Cytocentrifuge. Each spot was delimitedTable 1
Sequences of oligos used in Real-Time qPCR analysis.
Gene symbol Gene name
UVRAG UV Radiation Resistance Associated
VPS11 Vacuolar Protein Sorting 11
VPS 18 Vacuolar Protein Sorting 18
CSTF Cathepsin F
CSTB Cathepsin B
CSTD Cathepsin D
CSTA Cathepsin A
CSTE Cathepsin E
GBA Glucosidase, beta, acid
GUS Glucoronidase
CD63 CD63 molecule
KIF1Bβ kinesin family member 1B
KIF2A kinesin heavy chain member 2A
ARL8A ADP-ribosylation factor-like 8A
ARL8B ADP-ribosylation factor-like 8B
KIF3C kinesin family member 3C
β-actinwith theDakoPen (Dako, Denmark). Each sectionwasblockedwith nor-
mal goat serumbefore staining and then treatedwith amix of 1:100 LC3
(Biorbyt, Cambridge, UK) and 1:100 lysosome-associated membrane
protein (LAMP) (Biorbyt, Cambridge, UK) antibodies. Appropriate
anti-rabbit or anti-mouse peroxidase-linked secondary antibodies
were used. Nuclear counterstain was visualized with DAPI (4′,6-
diamidino-2-phenylindole, 0.05 mg/ml (Vector Laboratories, CA, USA).
Images were acquired by a confocal microscope (LSM 510, Zeiss,
Germany).
2.6. Statistics
GraphPad Prism softwarewas used for data analysis. The Student's t-
test was used to analyze the statistical signiﬁcance of differences. The
minimum acceptable level of signiﬁcance was p ≤ 0.05 calculated
through two-tailed unpaired Student's t-test and CHI Test.
3. Results
3.1. Lymphocytes from patients affectedwith A-T showaccumulation of APs
To address the involvement of an abnormal autophagic process in
the pathogenesis of A-T, we ﬁrst analyzed, under TEM, the lymphocytes
isolated from A-T patients or healthy controls maintained in normal
culture conditions or in a serum-starved condition, which is a classical
pro-autophagic stimulus. Ultrastructural analysis of healthy control
lymphocytes by TEM showed the morphological aspects of a cell in
unstarved culture conditions (Fig. 1A) and the accumulation of autoph-
agic vesicles (AVs) at different maturation stages (i.e. APs and ALs) in a
cell after serum starvation for 2 h (Fig. 1B). Ultrastructural analysis of
lymphocytes from A-T patients at basal conditions revealed a general
increase in AV size and number (Fig. 1C–F) not observed in healthy
control cells.
Next we analyzed distinct types of AVs, such as APs and ALs. TEM
revealed that A-T patients exhibit a higher number of APs and a
decrease in ALs, as compared to healthy subjects (mean: 13.60 vs
2.30/100 μm2; p = 0.03; mean: 2.10 vs 4.7/100 μm2 respectively)
(Fig. 1G). This suggests that fusion of APs to lysosomes and, thus, their
conversion to autolysosomes, could be impaired in A-T. A further
quantitative analysis of ALs revealed that, in the A-T patients, they
were not detected in the majority of the ﬁelds analyzed, differently
from the controls (83 vs 36% ALs negative ﬁelds, respectively;
p b 0.01) (Fig. 1H), resulting in an APs/ALs ratio much higher in theSequence (5′-3′)
Forward primer Reverse primer
TGACAATTCGTTGCAGGCAGTTA AGGCAACTTGACACCGCATACA
CCACTTTGATGTGGAGACAGC TGTATCGAAGGGCTTCCTGA
AGCGTCGCTACCTGGAGAG GTACGTTCGGCTGGCTTC
ACAGAGGAGGAGTTCCGCACTA GCTTGCTTCATCTTGTTGCCA
AGTGGAGAATGGCACACCCTA AAGAAGCCATTGTCACCCCA
AACTGCTGGACATCGCTTGCT CATTCTTCACGTAGGTGCTGGA
CAGGCTTTGGTCTTCTCTCCA TCACGCATTCCAGGTCTTTG
GGACATGATCCAGTTCACCGA GGTTGGCACACTCCACAGCA
TGGGTACCCGGATGATGTTA AGATGCTGCTGCTCTCAACA
ATTGGAGGTGCAGCTGACTG TCCTCATGCTTGTTGACACC
TCACGTTTGCCATCTTTCTG TCGAAGCAGTGTGGTTGTTT
GACCAAGCTCAGTGGTCTCTAAG CCAGATGACCTGGTCGTATTGTGC
GCCTTTGATGACTCAGCTCC TTCCTGAAAAGTCACCACCC
AGTCCTGGGTAACAAGCGAGAC GCAAGAGATGGAGTAGCAGCAG
CACCTTCGTCAATGTCATCG CCTATGTCCCAGATCTTTATTGTG
GAAGATGCTGGAGGACCTGCGG GTAGGTGCCCCGGAGCTCCATAG
GACAGGATGCAGAAGGAGAT TTGCTGATCCACATCTGCTG
Fig. 1. Lymphocytes from patients affected with A-T show accumulation of autophagosomes. (A–B) Electron micrographs of freshly isolated lymphocytes from healthy controls in
unstarved culture conditions or after serum starvation for 2 h showing the accumulation of autophagic vesicles (AVs). Scale bar: 500 nm. (C–F) Electron micrographs of lymphocytes
isolated from A-T patients at basal conditions showing a general engulfment of AVs. (D) Autophagosomal vesicles (black arrows) with a double-membrane proﬁle in the process of
engulfment of targeted organelles. (E) Autolysosomes (ALs) (white arrows) containing degraded material. (F) Vacuolar structures in the late stage of the autophagolysosomal
pathway. Scale bar: 1 μm. (G) Number of autophagic vesicles/100 μm2 in freshly isolated lymphocytes from healthy controls and A-T patients. (H) Percentage of AL negative ﬁelds in
fresh isolated lymphocytes from healthy controls and A-T patients. (I) APs/ALs ratio for freshly isolated lymphocytes from healthy controls and A-T patients. (J) Number of
autophagosomes/100 μm2 in freshly isolated lymphocytes from healthy controls and A-T patients at basal conditions and after serum starvation for 2 h. (Data expressed as mean ±
S.D.; *p= 0.03; **p b 0.01; ***p b 0.05. Representative image, n= 3 subjects per group).
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the APs number did not further increase under starvation in patient
cells, indicating that in A-T an inhibition of autophagy ﬂux rather than
a stimulation of AP biogenesis occurs (Fig. 1J).
The formation of LC3 puncta is observed in cells during autophagic
activation [19]. To further conﬁrm that in A-T patients the autophagy
was present at basal conditions, we tested the presence of LC3 puncta
in lymphocytes from both A-T patients and controls. Immunoﬂuores-
cence analysis documented the presence of LC3 puncta in A-T patients
but not in the controls, who showed a diffuse staining pattern of LC3
(Fig. 2A). Moreover, as shown in Fig. 2A, in few lymphocytes from A-T
patients the LC3 marker co-localized with LAMP2, in contrast to thecontrols, where no merge signal between LC3 and LAMP2 was docu-
mented. This result indicates that in the patients, even at basal condi-
tions, autophagy was detectable, since the presence of the merge
signal indicates that the fusion between APs and lysosomes occurred.
A quantitative analysis of LC3 positive cells, revealed that in A-T patients
the percentage of cells with a puncta pattern was much higher than in
the controls (82 vs 12.25%) (Fig. 2B) and that in A-T patients about 4/5
of the total amount of LC3 molecules contained in the cells showed
the puncta staining pattern (82% puncta vs 18% non-puncta;
*p b 0.005), thus resulting in a LC3 puncta cells/LC3 non-puncta cells
ratio much higher in the patients than in the controls (6.56 vs 0.37)
(Fig. 2B).
Fig. 2.Autophagy is active in lymphocytes fromA-T patients at basal conditions. (A) Representative images of freshly isolated lymphocytes fromhealthy controls and A-T patients showing
autophagosomes expressing LC3 marker (green punctate dots), lysosomes expressing LAMP2 marker (red dots) and autolysosomes (yellow dots). Cells were imaged by ﬂuorescence
microscopy. (B) Percentage of autophagic vesicles positive for LC3 marker and LC3 puncta cells/LC3 non-puncta cells ratio in freshly isolated lymphocytes from healthy controls and A-
T patients (data expressed as mean ± S.E.; *p b 0.005; representative image, n= 4 subjects per group). (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
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is associated to a reduced expression level of Vps18 mRNA
Autophagy consists of two consecutive stages: the early stage when
the APs biogenesis occurs and the late stage characterized by the fusion
between APs and endosomes-lysosomes, which leads to the formation
of ALs, where the damaged proteins and the entire organelles are
degraded by the lysosomal hydrolases and recycled to generate building
blocks for anabolic processes. Of note, a normal biogenesis and function
of lysosomes and their positioning in the cell, are essential for a proper
autophagic process. Since several genes are activated during the
process, playing different roles in the different steps, we analyzed
through quantitative real-time PCR the relative expression levels of an
array of genes differentially involved in the process.
In A-T patients at basal conditions, mRNA expression level of UVRAG,
involved in the biogenesis of APs, was higher than controls (Fig. 3A), in
keeping with the data obtained by TEM. The evaluation of the mRNA
expression level of genes involved in the lysosome biogenesis and
function (CSTF, CSTB, CSTD, GBA, GUS, CD63, CSTA, CSTE) revealed that,
in A-T patients, at basal conditions, the expression of 6 out of the 8
genes analyzed was much higher than in the controls (Fig. 3B), whileunder starvation conditions the expression was comparable (data not
shown), thus suggesting that in A-T, at basal conditions, the activation
of the process was constitutively high. Taken together the results
indicate that in A-T patients, the generation of both the APs and the
lysosomes is very active. Moreover, the increased expression of 4 out
of 5 cathepsins (CSTB, CSTD, CSTA, CSTE) and of the GBA hydrolase
mRNAs in A-T at basal conditions indicates that lysosomal functionality
is activated, as well (Fig. 3B).
Sincewe observed an inappropriate APs/ALs ratio at themorpholog-
ical studies in A-T, we also evaluated the expression level of Vps11 and
Vps18 mRNAs, whose products are involved in vesicular trafﬁcking
and fusion. As shown in Fig. 3C, at basal conditions, both Vps11 and
Vps18 are less expressed in the patients than in the controls. The
expression level of Vps18 did not increase even after serum starvation,
as compared to control expression.
To allow the encounter between APs and lysosomes, the vesicles
have to be in the perinuclear zone. Since in the presence of nutrients,
the lysosomes are linked to the plasmatic membrane through kinesins,
we also evaluated the expression level of KIF1Bβ, KIF2A, ARL8A, ARL8B
and KIF3C. As shown in Fig. 3D, at basal conditions, all the kinesins,
and in particular the KIF3C molecule, were more expressed in A-T
Fig. 3. The accumulation of autophagosomes in lymphocytes from A-T patients is associated to a reduced expression level of Vps18mRNA. (A–B) Relative mRNA expression level of genes
involved in the biogenesis of APs (UVRAG) and in lysosome biogenesis and function (CSTF, CSTB, CSTD, GBA, GUS, CD63, CSTA, CSTE), in freshly isolated lymphocytes from healthy controls
and A-T patients, at basal conditions and after serum starvation for 2 h. (C–D) Relative mRNA expression level of genes involved in vesicular trafﬁcking and fusion (Vps11 and Vps18), at
basal conditions and after serum starvation for 2 h, and in lysosomal positioning in the cell (KIF1Bβ, KIF2A, ARL8A, ARL8B and KIF3C) in freshly isolated lymphocytes from healthy controls
and A-T patients, at basal conditions (data are expressed as mean ± S.E.; n= 3 subjects per group).
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located in the peripheral zone of the cell, not favoring the fusion process
between the vesicles.
3.3. Autophagy is increased in A-T patients despite an activated mTOR
pathway
mTORC1 is an important sensor in regulating cell proliferation and
inhibiting autophagy [28]. Several pathways regulate its activation,
which eventually results in the phosphorylation of downstream targets
S6K, S6 and 4EBP1, involved in protein synthesis and survival. By
contrast, ATM inhibits mTORC1. We investigated the phosphorylation
status of mTOR (Fig. 4A) and its downstream targets at basal conditions
and after treatment with H2O2 at different time points (Fig. 4B). We
found that in lymphoblastoid cell lines fromA-T patients, the phosphor-
ylation status of mTOR, S6K, S6 and 4EBP1 proteins, was increased, in
particular after 30′ and 60′ of treatment with H2O2, indicating that in
A-T patients mTORC1 is active, and that autophagy mechanism isinhibited. Collectively, these data suggest that in A-T patients there is
a lower ATM-mediated inhibition on mTORC1 and of its downstream
molecules, as compared to the control.
3.4. Betamethasone pre-treatment promotes autophagy inducing
autophagosome formation and degradation
SQSTM1/p62 and LC3 are the canonical markers to evaluate the
autophagic process. In particular, SQSTM1/p62 translocates to the
autophagosome formation site, where it is incorporated and then
degraded [29]. Its accumulation reveals an impaired autophagic ﬂux
[19]. LC3-II amount correlates with the number of autophagosomes,
and is used as indicator of the autophagosome formation [30]. BAFA1,
a speciﬁc inhibitor of vacuolar-type H+ ATPase of the lysosome,
increases LC3-II levels, mainly during H2O2 induced stress, indicating
that a normal ﬂux occurs. We showed that in lymphoblastoid cells
from A-T patients, at basal conditions, SQSTM1 levels are accumulated
as compared to controls (Fig. 5A). Such increase was more evident in
Fig. 4. Autophagy is increased in A-T patients despite an activated mTOR pathway. Lymphoblastoid cells from the A-T patient and control were treated with 0.2 mM of H2O2 for different
time points. (A) Fractioned lysates were loaded for detection of mTOR and p-mTOR. (B) Fractioned lysates were also loaded on another gel, for detection of p-S6K, p-S6, p-4EBPI and
housekeeping protein. (C) p-mTOR/mTOR ratio in lymphoblastoid cells from the A-T patient and control.
Fig. 5. Betamethasone pre-treatment promotes autophagy inducing autophagosome formation and degradation. (A) Lymphoblastoid cells from the A-T patient and healthy control were
pre-treated or not with Betamethasone (BMZ) (80 nM) for 2 h, and H2O2 (0.2mM) for 0.5 h in the presence or absence of 100 nMBaﬁlomycin (BAFA1) as indicated.Western blottingwas
performed to analyze the status of LC3, SQSTM1 and Tubulin.
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for 1 hwith BAFA1, we found that degradation of SQSTM1was inhibited
(Fig. 5A), as expected. Furthermore, a synergic effect of H2O2 and BAFA1
treatment resulted in a remarkable increase of SQSTM1 level (Fig. 5A).
We also provided evidence that, in lymphoblasts from A-T patients at
basal conditions, BMZ pre-treatment is able to promote the degradation
of SQSTM1, as shown in Fig. 5A. However, BMZ is ineffective in
counteracting the effect on the molecule of the H2O2 induced stress
(Fig. 5A). By contrast, BMZ is able to counteract the inhibitory effect of
the BAFA1 on SQSTM1 level (Fig. 5A). In the control, BMZ per se
promotes the degradation of SQSTM1. As expected, BAFA1 increased
LC3-II expression under the condition of H2O2 induced stress. This
increase was even more evident after BMZ pre-treatment. In particular,
the overexpression of LC3-II after BAFA1 treatment, suggests an
enhancement of the autophagic ﬂux and a BMZ positive effect on the
modulation of the autophagic process.
Collectively, these results suggest that in A-T patients the process of
APs maturation is active, while the fusion process between APs and ALs
is inappropriate, the latter being the overall limiting step in the
autophagic process. Moreover, we documented a positive effect of
Betamethasone pre-treatment on molecules implicated in the cell
clearance apparatus and promotion of autophagosome formation and
subsequent degradation.
4. Discussion
In the present studywe documented that lymphocytes isolated from
A-T patients are characterized by an accumulation of APs, associated
with a high expression of genes involved in the process of biogenesis
and function of APs. This accumulation is not coupled to a parallel
formation of autolysosomes, indicating the inappropriateness of the
cell clearance apparatus, which ultimately results in the morphological
appearance at the TEM of cytoplasmic engulfment of waste material.
Autophagy is markedly induced by stress conditions, such as
starvation, and has twomajor purposes: to recycle essential macromol-
ecules and energy to be reused in conditions of nutritional scarcity or to
clear cells from altered intracellular components [31].
Autophagy is a dynamic ﬂux including vesicle biogenesis, fusion
between APs and lysosomes and, eventually, content degradation, and
thus the increased number of APs herein observed may be due to an
increased biogenesis or to a reduced degradation of the vesicles after
the fusion with the lysosomes.
Moreover, it has recently been reported by Park et al. [32] that
autophagy is upregulated in response to DNAdamage and that impaired
cell cycle progression mediated through the checkpoint kinase 1
(Chk1), that allows DNA repair, affects the functionality of autophagy.
In keepingwith the data obtained by TEM, documenting an accumu-
lation of APs, we found in A-T lymphocytes, an increased expression of
the UVRAG mRNA, which is speciﬁcally involved in the initial step of
formation of APs, thus conﬁrming, also at molecular level, that the
stage of biogenesis of APs properly occurs in A-T patients. Moreover,
the evaluation of CD63, which is expressed on lysosomal membrane,
revealed an increased mRNA expression in A-T lymphocytes, indicating
a proper lysosomal biogenesis.
An accumulation of APs may be due to abnormalities of regulatory
molecules [33]. Among the genes involved in lysosome functionality,
cathepsins, lysosomal hydrolases belonging to the cysteine protease
family A, B, D and F, and β-glucosidase and β-glucuronidase, help
degrade unwanted intracellular or endocytosed proteins [21]. In brain
neurons of CST D−/− or CST B−/−/CST L−/− mice, the lack of CST is
responsible for the absence of protein degradation, which results in
the accumulation of vacuolar structures, a feature similar to that
observed in A-T lymphocytes. CST E is an intracellular aspartic protein-
ase that is predominantly distributed in immune-related cells. The lack
of CST E induces several abnormal membrane trafﬁcking events
resulting in the impairment of autophagic ﬂux and the accumulationof toxic proteins and/or damaged organelles [34]. CST A is a serine
protease, which regulates the lysosomal activity and stability of several
lysosomal enzymes such as glycosidases, beta-D-galactosidase, as well
as the transport of neuraminidase to mature lysosomes. CST A also
triggers the degradation of LAMP 2A receptor involved in the autopha-
gic process [35]. Similarly, in macrophages, the absence of CST S
promotes an accumulation of APs [36], thus indicating a regulatory
role for cathepsin family molecules. However, in A-T patients, even in
unstimulated conditions, the mRNA expression levels of these
proteases, CSTB, CSTD, GBA, CSTA and CSTE, are increased, thus indicating
a constitutive hyperactivation of the lysosomal functionality. These data
argue against the possibility that the accumulation of APs in A-T could
be related to a reduced hydrolase activity.
The positioning of lysosomes plays an important role in that, only
the lysosomes localized in the perinuclear area of the cell are able to
fuse with APs and promote the cell clearance [24]. The subcellular re-
distribution of lysosomes mostly relies on their transport along
microtubules mediated by the kinesins. The process ultimately leads
to the formation of ALs where the degradation occurs. In this study,
we found an overexpression in A-T cells of the kinesins KIF2A and
KIF1B-β and the monomeric GTPase ARL8B and its close homolog
ARL8A. A very impressive increase in KIF3C expression was also found.
These results further support the inappropriateness in the process of
lysosomal trafﬁcking, which does not parallel AP formation, thus
impairing the autophagic ﬂux. By contrast, the A-T lymphocytes show
a reduced expression of Vps18 and Vps11 mRNAs, whose protein
products are involved in the vesicular trafﬁcking and fusion between
APs and lysosomes [25,37]. Both Vps11 and Vps18 are subunits of the
Vps-C core complex also composed of Vps16 and Vps33 [38]. In
eukaryotic organisms, the Vps-C complex acts as a tethering factor in
endosome- and lysosome-related vesicle fusion process. In particular,
the down-regulation of Vps18, by knocking-down or by using anti-
Vps18 antibody, blocks AP-lysosome and early endosome fusion,
leading to an accumulation of APs and late endosomes in yeast [38].
Additional data demonstrate that Vps18 plays a prominent role in the
process [39]. However, the immunoﬂuorescence staining experiments
revealed that, at a certain extent, the fusion process between APs and
lysosomes in A-T cells did take place. Thus, we would argue that the
reduced expression of Vps11 and Vps18 represents the limiting factor
of the process that does not allow an autophagic ﬂux at a proper extent.
Overall, the data herein reported indicate that the accumulation of APs
may be due to the inefﬁcacy of their degradation as a consequence of
the reduced fusion process amongAPs and lysosomes in the perinuclear
zone, determined by an altered regulatory control of the process. The
increase in kinesins expression may be interpreted as an attempt to
overcome the inappropriate AP-lysosome fusion process.
Taken together our data indicate that, in A-T lymphocytes, the fusion
step between APs and lysosomes represents the limiting factor in the
autophagy process.
Besides the nuclear activity of ATM, there is evidence that the
molecule is also localized in the cytosol, within synaptosomal fractions
[40], and, in particular, on the peroxisomes [41], where it induces
pexophagy in response to ROS [42]. It is also well documented that
ATM, in the cytosol, has a role in the autophagy pathway [12]. In fact,
in the presence of elevated ROS levels, ATM activates the tumor
suppressor TSC2, through the LKB1/AMPK pathway, to inhibit
mTORC1 and, in turn, induces autophagy [43]. In this study, we
documented in lymphoblasts from A-T patients, an increase of the
phosphorylated S6K, S6 and 4EBP1 proteins, which are mTORC1
substrates, and, in particular, under stress conditions. This is in keeping
with the inhibitory effect of ATM on mTORC1 signaling. In addition, the
increased p-mTOR/mTOR ratio in A-T patients, under stress conditions,
further supports the ATM-mediated inhibition of mTORC1. Since in this
study we found an accumulation of APs, this would imply that
autophagy is a complex process and that the phase of AP formation is
dependent on different regulatory pathways, which are not dependent
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herein described, directly depends on the absence of ATM mediated
control of the pathway upstream to mTORC1 or rather to the defect in
DNA repair remains to be further clariﬁed.
Several studies have focused on the relationship between
glucocorticoids and autophagy. It is known that GCs are able to induce
autophagy in different cell types [44,45], even though the explanation
of the intimate molecular mechanism by which these drugs lead to
this effect is not fully clear.
In the attempt to explain the beneﬁcial effect of the steroids in A-T,
we evaluated the effect of Betamethasone on molecular targets
implicated in autophagy. We found that Betamethasone pre-treatment
promoted the degradation of SQSTM1 protein, which was accumulated
in lymphoblastoid cells obtained from A-T patients. The degradation of
this protein is generally considered to parallel the progression of
autophagy. We also found an accumulation of LC3-II protein after BMZ
treatment, suggesting an enhancement of the autophagic ﬂux and a
Betamethasone-mediated positive effect on the process.
In conclusion, we provide evidence of the inadequacy of the cell
clearance apparatus in the cells from A-T patients, characterized by an
accumulation of un-degraded APs. The molecular studies led us to
identify the fusion process between APs and lysosomes the limiting
step in the overall process. To address the issue of whether the
alterations observed in lymphocytes from A-T patients could also be
responsible for neurodegeneration, further studies will be planned in
ATM−/− neuronal cell lines.
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